ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 159 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2021. The put-call ratio across all filers is 3.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $19,032 | -74.5% | 11,970 | 0.0% | 0.00% | – |
| Q4 2022 | $74,573 | +113.1% | 11,970 | +307.0% | 0.00% | – |
| Q3 2021 | $35,000 | -43.5% | 2,941 | 0.0% | 0.00% | – |
| Q2 2021 | $62,000 | -24.4% | 2,941 | 0.0% | 0.00% | – |
| Q1 2021 | $82,000 | +7.9% | 2,941 | 0.0% | 0.00% | – |
| Q4 2020 | $76,000 | -30.3% | 2,941 | 0.0% | 0.00% | -100.0% |
| Q3 2020 | $109,000 | -27.8% | 2,941 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $151,000 | +122.1% | 2,941 | +36.2% | 0.00% | 0.0% |
| Q1 2020 | $68,000 | -16.0% | 2,159 | +59.8% | 0.00% | 0.0% |
| Q4 2019 | $81,000 | +62.0% | 1,351 | 0.0% | 0.00% | – |
| Q3 2019 | $50,000 | -20.6% | 1,351 | 0.0% | 0.00% | -100.0% |
| Q2 2019 | $63,000 | +16.7% | 1,351 | 0.0% | 0.00% | – |
| Q1 2019 | $54,000 | -12.9% | 1,351 | 0.0% | 0.00% | -100.0% |
| Q4 2018 | $62,000 | +3.3% | 1,351 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $60,000 | +30.4% | 1,351 | +15.7% | 0.00% | – |
| Q2 2018 | $46,000 | -45.2% | 1,168 | 0.0% | 0.00% | -100.0% |
| Q1 2018 | $84,000 | +9.1% | 1,168 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $77,000 | +92.5% | 1,168 | +47.1% | 0.00% | – |
| Q3 2017 | $40,000 | +73.9% | 794 | +56.9% | 0.00% | – |
| Q2 2017 | $23,000 | +27.8% | 506 | 0.0% | 0.00% | – |
| Q1 2017 | $18,000 | +200.0% | 506 | 0.0% | 0.00% | – |
| Q4 2016 | $6,000 | -14.3% | 506 | 0.0% | 0.00% | – |
| Q3 2016 | $7,000 | +40.0% | 506 | 0.0% | 0.00% | – |
| Q2 2016 | $5,000 | -44.4% | 506 | 0.0% | 0.00% | – |
| Q1 2016 | $9,000 | -18.2% | 506 | 0.0% | 0.00% | – |
| Q4 2015 | $11,000 | +120.0% | 506 | +122.9% | 0.00% | – |
| Q3 2015 | $5,000 | -61.5% | 227 | +39.3% | 0.00% | – |
| Q2 2015 | $13,000 | +44.4% | 163 | +63.0% | 0.00% | – |
| Q1 2015 | $9,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 4,468,835 | $22,344,000 | 10.09% |
| Altium Capital Management LP | 2,515,785 | $12,579,000 | 3.47% |
| Deep Track Capital, LP | 5,641,668 | $28,208,000 | 1.99% |
| Paradigm Biocapital Advisors LP | 839,257 | $4,196,000 | 1.20% |
| SABBY MANAGEMENT, LLC | 940,400 | $4,702,000 | 0.68% |
| Monaco Asset Management SAM | 500,000 | $2,500,000 | 0.62% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,000,000 | $25,000,000 | 0.52% |
| CVI Holdings, LLC | 1,460,595 | $7,303,000 | 0.48% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,713,176 | $13,566,000 | 0.38% |
| Rhenman & Partners Asset Management AB | 1,000,000 | $4,960,000 | 0.33% |